These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
851 related items for PubMed ID: 16322285
21. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck. Zushi Y, Noguchi K, Hashitani S, Sakurai K, Segawa E, Takaoka K, Toyohara Y, Tanaka N, Kishimoto H, Urade M. Int J Oncol; 2008 Dec; 33(6):1133-9. PubMed ID: 19020745 [Abstract] [Full Text] [Related]
22. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Bajetto A, Barbieri F, Pattarozzi A, Dorcaratto A, Porcile C, Ravetti JL, Zona G, Spaziante R, Schettini G, Florio T. Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064 [Abstract] [Full Text] [Related]
23. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Tang CH, Tan TW, Fu WM, Yang RS. Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907 [Abstract] [Full Text] [Related]
24. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, Hwang ST. Cancer Res; 2002 Dec 15; 62(24):7328-34. PubMed ID: 12499276 [Abstract] [Full Text] [Related]
25. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. Am J Respir Crit Care Med; 2003 Jun 15; 167(12):1676-86. PubMed ID: 12626353 [Abstract] [Full Text] [Related]
31. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Wang L, Lin SH, Wu WG, Kemp BL, Walsh GL, Hong WK, Mao L. Clin Cancer Res; 2000 Aug 15; 6(8):2988-93. PubMed ID: 10955775 [Abstract] [Full Text] [Related]
33. S100A2 induces metastasis in non-small cell lung cancer. Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, Hotfilder M, Marra A, Koschmieder S, Dugas M, Berdel WE, Serve H, Müller-Tidow C. Clin Cancer Res; 2009 Jan 01; 15(1):22-9. PubMed ID: 19118029 [Abstract] [Full Text] [Related]
35. CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Xu L, Zhou Y, Liu Q, Luo JM, Qing M, Tang XY, Yao XS, Wang CH, Wen ZK. Biochem Biophys Res Commun; 2009 May 08; 382(3):571-6. PubMed ID: 19302975 [Abstract] [Full Text] [Related]
36. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. Carcinogenesis; 2003 Sep 08; 24(9):1445-54. PubMed ID: 12819188 [Abstract] [Full Text] [Related]
37. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J, Zhu CQ, Bandarchi B, Wang YH, Navab R, Shepherd FA, Jurisica I, Tsao MS. Clin Cancer Res; 2012 Apr 01; 18(7):1914-24. PubMed ID: 22307136 [Abstract] [Full Text] [Related]
39. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N. Cancer Res; 2004 Jun 15; 64(12):4190-6. PubMed ID: 15205330 [Abstract] [Full Text] [Related]